FIS

FCPM III Services Portfolio holdings

AUM $500M
1-Year Est. Return 11.2%
This Quarter Est. Return
1 Year Est. Return
+11.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$500M
AUM Growth
+$131M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
9
New
Increased
Reduced
Closed

Top Buys

1
+$18.5M
2
+$1.04M

Top Sells

1
+$40.4M
2
+$2.47M

Sector Composition

1 Healthcare 99.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$4.03B
$262M 52.36%
9,212,384
-1,419,729
DYN icon
2
Dyne Therapeutics
DYN
$2.87B
$69.1M 13.81%
5,462,846
ENGN icon
3
enGene Holdings
ENGN
$535M
$65.8M 13.15%
9,632,561
ATXS icon
4
Astria Therapeutics
ATXS
$747M
$29.9M 5.98%
4,107,537
BCYC
5
Bicycle Therapeutics
BCYC
$495M
$26.7M 5.34%
3,452,330
VOR icon
6
Vor Biopharma
VOR
$186M
$18.5M 3.7%
+379,640
REPL icon
7
Replimune Group
REPL
$810M
$17.4M 3.48%
4,158,368
+248,672
RAPT icon
8
RAPT Therapeutics
RAPT
$889M
$8.88M 1.77%
344,237
-95,939
ENGNW icon
9
enGene Holdings Warrants
ENGNW
$26M
$2.07M 0.41%
2,878,148